TY - JOUR
T1 - U.S. Preventive Services Task Force Priorities for Prevention Research
AU - Mabry-Hernandez, Iris R.
AU - Curry, Susan J.
AU - Phillips, William R.
AU - García, Francisco A.
AU - Davidson, Karina W.
AU - Epling, John W.
AU - Ngo-Metzger, Quyen
AU - Bierman, Arlene S.
N1 - Funding Information:
Publication of this article was supported by the Agency for Healthcare Research and Quality (AHRQ) through contract #HHSA290201600006C. The U.S. Preventive Services Task Force (USPSTF) is an independent, voluntary body. The U.S. Congress mandates that AHRQ support the operations of the USPSTF. The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or the U.S. Department of Health and Human Services. No financial disclosures were reported by the authors of this paper.
Publisher Copyright:
© 2017
PY - 2018/1
Y1 - 2018/1
N2 - The U.S. Preventive Services Task Force (USPSTF) makes recommendations about clinical preventive services. The USPSTF examines chains of direct and indirect evidence to demonstrate the effectiveness of a clinical preventive service. Missing links across the chains of evidence reflect gaps in the research. Evidence gaps can occur for preventive services that receive a letter grade recommendation and those that receive an I statement (insufficient evidence). This article describes the types of evidence gaps that the USPSTF encounters across its various recommendations and how the USPSTF identifies and communicates these gaps to researchers and policymakers, who can help generate the needed evidence. Common types of evidence gaps include limited evidence in primary care settings and populations, a lack of appropriate health outcomes, limited evidence linking behavior change to health outcomes, and a lack of evidence for effective preventive services in diverse populations. The USPSTF annual report to Congress focuses on the evidence gaps of new recommendations from the past year and is sent to leading research funding agencies. The Office of Disease Prevention at NIH uses this report to help direct future funding opportunities that may address these evidence gaps. The USPSTF plays a critical role in highlighting the information needed to advance the science to optimize the use of clinical preventive services in primary care.
AB - The U.S. Preventive Services Task Force (USPSTF) makes recommendations about clinical preventive services. The USPSTF examines chains of direct and indirect evidence to demonstrate the effectiveness of a clinical preventive service. Missing links across the chains of evidence reflect gaps in the research. Evidence gaps can occur for preventive services that receive a letter grade recommendation and those that receive an I statement (insufficient evidence). This article describes the types of evidence gaps that the USPSTF encounters across its various recommendations and how the USPSTF identifies and communicates these gaps to researchers and policymakers, who can help generate the needed evidence. Common types of evidence gaps include limited evidence in primary care settings and populations, a lack of appropriate health outcomes, limited evidence linking behavior change to health outcomes, and a lack of evidence for effective preventive services in diverse populations. The USPSTF annual report to Congress focuses on the evidence gaps of new recommendations from the past year and is sent to leading research funding agencies. The Office of Disease Prevention at NIH uses this report to help direct future funding opportunities that may address these evidence gaps. The USPSTF plays a critical role in highlighting the information needed to advance the science to optimize the use of clinical preventive services in primary care.
UR - http://www.scopus.com/inward/record.url?scp=85038071744&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038071744&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2017.08.014
DO - 10.1016/j.amepre.2017.08.014
M3 - Article
C2 - 29254531
AN - SCOPUS:85038071744
SN - 0749-3797
VL - 54
SP - S95-S103
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
IS - 1
ER -